scholarly journals Identifying optimal dosage regimes under safety constraints: An application to long term opioid treatment of chronic pain

2018 ◽  
Vol 37 (9) ◽  
pp. 1407-1418 ◽  
Author(s):  
Eric B. Laber ◽  
Fan Wu ◽  
Catherine Munera ◽  
Ilya Lipkovich ◽  
Salvatore Colucci ◽  
...  
2007 ◽  
Vol 3;10 (5;3) ◽  
pp. 479-491 ◽  
Author(s):  
Jane C. Ballantyne

The ability of opioids to effectively and safely control acute and cancer pain has been one of several arguments used to support extending opioid treatment to patients with chronic pain, against a backdrop of considerable caution that has been based upon fears of addiction. Of course, opioids may cause addiction, but the “principle of balance” may justify that “…efforts to address abuse should not interfere with legitimate medical practice and patient care.” Yet, situations are increasingly encountered in which opioid-maintained patients are refractory to analgesia during periods of pain, or even during the course of chronic treatment. The real question is whether analgesic efficacy of opioids can be maintained over time. Overall, the evidence supporting long-term analgesic efficacy is weak. The putative mechanisms for failed opioid analgesia may be related to tolerance or opioid-induced hyperalgesia. Advances in basic sciences may help in understanding these phenomena, but the question of whether long-term opioid treatment can improve patients’ function or quality of life remains a broader issue. Opioid side effects are well known, but with chronic use, most (except constipation) subside. Still, side effects can negatively affect the outcomes and continuity of therapy. This paper addresses 1) what evidence supports the long-term utility of opioids for chronic pain; 2) how side effects may alter quality of life; 3) the nature of addiction and why it is different in pain patients, and 4) on what grounds could pain medication be denied? These questions are discussed in light of patients’ rights, and warrant balancing particular responsibilities with risks. These are framed within the Hippocratic tradition of “producing good for the patient and protecting from harm,” so as to enable 1) more informed clinical decision making, and 2) progress towards right use and utility of opioid treatment for chronic pain. Key Words: Opioids, chronic pain, addiction, side effects, utility, ethics


Pain ◽  
2004 ◽  
Vol 110 (1) ◽  
pp. 182-188 ◽  
Author(s):  
Lowell Reynolds ◽  
Richard Rauck ◽  
Lynn Webster ◽  
Stuart DuPen ◽  
Everett Heinze ◽  
...  

2020 ◽  
Vol 35 (3) ◽  
pp. 209-217 ◽  
Author(s):  
Jennifer R. Fonda ◽  
Jaimie L. Gradus ◽  
Susan B. Brogly ◽  
Regina E. McGlinchey ◽  
William P. Milberg ◽  
...  

2022 ◽  
pp. BJGP.2021.0537
Author(s):  
Loes de Kleijn ◽  
Julie Pedersen ◽  
Hanneke Rijkels-Otters ◽  
Alessandro Chiarotto ◽  
Bart Koes

Background: Long-term opioid treatment in patients with chronic pain is often ineffective and possibly harmful. These patients are often managed by general practitioners, who are calling for a clear overview of effective opioid reduction strategies for primary care. Aim: Evaluate effectiveness of opioid reduction strategies applicable in primary care for patients with chronic pain on long-term opioid treatment. Design: Systematic review of controlled trials and cohort studies. Method Literature search conducted in Embase, Medline, Web of Science, Cochrane CENTRAL register of trials, CINAHL, Google Scholar and PsychInfo. Studies evaluating opioid reduction interventions applicable in primary care among adults with long-term opioid treatment for chronic non-cancer pain were included. Risk of bias was assessed using Cochrane risk of bias (RoB) 2.0 tool or Risk-of-Bias in Non-randomized studies of Interventions (ROBINS-I) tool. Narrative synthesis was performed due to clinical heterogeneity in study designs and types of interventions. Results: Five RCTs and five cohort studies were included (total n= 1717, range 35-985) exploring various opioid reduction strategies. Six studies had high RoB, three moderate RoB, and one low RoB. Three cohort studies investigating a GP supervised opioid taper (critical ROBINS-I), an integrative pain treatment (moderate ROBINS-I) and group medical visits (critical ROBINS-I) demonstrated significant between-group opioid reduction. Conclusion: Results carefully point in the direction of a GP supervised tapering and multidisciplinary group therapeutic sessions to reduce long term opioid treatment. However, due to high risk of bias and small sample sizes, no firm conclusions can be made demonstrating need for more high-quality research.


Author(s):  
Roger Chou ◽  
Rick Deyo ◽  
Beth Devine ◽  
Ryan Hansen ◽  
Sean Sullivan ◽  
...  

2012 ◽  
Vol 11 (2) ◽  
pp. 128-142 ◽  
Author(s):  
Tina A. Valkanoff ◽  
Andrea H. Kline-Simon ◽  
Stacy Sterling ◽  
Cynthia Campbell ◽  
Michael Von Korff

Sign in / Sign up

Export Citation Format

Share Document